Clinical Trials Insight: 700028805
Phase of Trial: Phase II
Latest Information Update: 14 Dec 2007
At a glance
- Drugs Bevacizumab; Erlotinib; IMO 2055
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Idera Pharmaceuticals
- 14 Dec 2007 Status changed from initiated to recruiting according to Idera Pharmaceuticals media release.
- 26 Nov 2007 New trial record.